Azitra, Inc. announced a private placement offering priced at a premium to market under NYSE rules.
The offering involves 4,687,500 shares of common stock and warrants.
Gross proceeds estimated at approximately $1.5 million before expenses.
Offer Details
Private placement of 4,687,500 shares of common stock.
Warrants
Accompanying warrants to purchase up to 4,687,500 shares.
Proceeds
Estimated gross proceeds of $1.5 million.
- Azitra aims to fund its innovative therapies for precision dermatology.
- Maxim Group LLC is the sole placement agent for the offering.
Azitra's private placement signifies investor confidence in its dermatology therapies and potential growth.